Liposomal formulations for enhanced lymphatic delivery

  • Kim, H.
  • Kim, Y.
  • Lee, J.
Citations

SCOPUS

31

초록

The lymphatic system that extends throughout the whole body is one of useful targetsfor efficient drug delivery. The intestinal lymphatic drug delivery has been actively studied to date because administered drugs can avoid the first-pass metabolism in the liver, resulting in improvement oforal bioavailability. Drugs must be hydrophobic in order to be transported into the intestinal lymphaticsbecause the lipid absorption mechanism in the intestine is involved in the lymphatic delivery. Therefore, various lipid-based drug carrier systems have been recently utilized to increase the transport of drug into the intestinal lymphatics. Lipidic molecules of the lipid-based drug delivery systems stimulate production of chylomicrons in the enterocytes, resulting in an increase in drug transport into lymphatic in the enterocytes. This review summarizes recently reported information on development of liposomal carriers for the intestinal lymphatic delivery and covers important determinants for successful lymphatic delivery.

키워드

BioavailabilityLiposomeLymphatic drug deliverycalcitonincatechincefotaximechylomicronclozapinecyclosporinhalofantrineliposomenanoparticleraloxifenerecombinant epidermal growth factorsolid lipid nanoparticletobramycinvinpocetinearticledrug bioavailabilitydrug delivery systemdrug formulationdrug solubilitydrug stabilitydrug transportemulsionfirst pass effecthumanhydrophobicityintestine absorptionintestine cellintestine lymphlipid absorptionlipophilicitymalariananoemulsionnonhumanparticle sizephysical chemistry
제목
Liposomal formulations for enhanced lymphatic delivery
저자
Kim, H.Kim, Y.Lee, J.
발행일
2013
유형
Article
저널명
Asian Journal of Pharmaceutical Sciences
8
2
페이지
100 ~ 109